Short Interest Coverage: What Will Happen to BIOELECTRONICS CORPORATION (OTCMKTS:BIEL) Next? The Stock Has Decline in Shorts

November 25, 2016 - By Hazel Jackson   ·   0 Comments

Short Interest Coverage: What Will Happen to BIOELECTRONICS CORPORATION (OTCMKTS:BIEL) Next? The Stock Has Decline in Shorts

The stock of BIOELECTRONICS CORPORATION (OTCMKTS:BIEL) registered a decrease of 70.88% in short interest. BIEL’s total short interest was 27,400 shares in November as published by FINRA. Its down 70.88% from 94,100 shares, reported previously. The stock last traded at $0.0004 per share. It is down 69.23% since April 28, 2016 and is downtrending. It has underperformed by 74.64% the S&P500.

BioElectronics Corporation is a development-stage company. The company has a market cap of $5.04 million. The Firm is a developer, marketer and maker of non-invasive electroceutical medical devices. It currently has negative earnings. The Company’s devices consist of a microchip, battery and antenna, and use therapies of heat and electric restoration of the body’s injured cells.

Insitutional Activity: The institutional sentiment decreased to 0 in Q2 2016. Its down Infinity, from Infinity in 2016Q1. The ratio dropped, as 0 funds sold all Bioelectronics Corp shares owned while 0 reduced positions. 1 funds bought stakes while 0 increased positions. They now own 344,000 shares or 105.99% more from 167,000 shares in 2016Q1.
The Ohio-based Winslow Asset Management has invested 0% in Bioelectronics Corp (OTCMKTS:BIEL). First Midwest Bancorporation Tru Division last reported 107,000 shares in the company. Pnc Financial Services Group has 0% invested in the company for 5,000 shares.

BIEL Company Profile

BioElectronics Corporation, incorporated on April 10, 2000, is a development-stage company. The Firm is a developer, marketer and maker of non-invasive electroceutical medical devices. The Company’s devices consist of a microchip, battery and antenna, and use therapies of heat and electric restoration of the body’s injured cells. The Company’s devices are used to treat acute and chronic pain, as well as to promote wound healing. The Company’s products cover a range of markets, including the ActiPatch for Musculoskeletal Pain, Smart Insole for Foot Care, Allay for Menstrual Pain, RecoveryRx for Chronic Wounds and Postoperative Recovery, and HealFast for cats, dogs and horses. The Firm has distribution agreements with distributors in Korea, Singapore, Malaysia, Canada, Columbia, Scandinavia, Saudi Arabia, the Balkans, Australia, China and South America.

More news for Bioelectronics Corp (OTCMKTS:BIEL) were recently published by: Marketwatch.com, which released: “BioElectronics Corp.” on April 16, 2011. Prnewswire.com‘s article titled: “BioElectronics Corporation Refutes SEC Order for Administrative Proceedings” and published on February 08, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Hazel Jackson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>